Clinical Trials Sponsored by Evolution Research Group

Total 1453 results

Ophirex, Inc.
Premier Research Group plc

Completed

Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite (BRAVO)

Snakebites | Envenoming | Envenoming, Snake | Envenomation, Snake

United States, India
Spanish Breast Cancer Research Group
Sanofi

Completed

Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment

Breast Neoplasms

Spain
Spanish Breast Cancer Research Group
Novartis

Completed

Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients (EDALINE)

Advanced Breast Cancer

Spain
Spanish Breast Cancer Research Group
Novartis

Completed

Pamidronate Administration in Breast Cancer Patients With Bone Metastases

Breast Cancer | Neoplasm Metastasis

Spain
Swiss Group for Clinical Cancer Research

Terminated

Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)

Squamous-cell Non-small Cell Lung Cancer

Switzerland
Cook Research Incorporated

Completed

Post-market Assessment of Biodesign Dural Repair Grafts

Cerebrospinal Fluid Leak

Canada, United States, Italy
Duchesnay Inc.
Premier Research Group plc

Completed

The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy

Nausea and Vomiting of Pregnancy

United States
Cook Research Incorporated

Completed

Fenestrated AAA Endovascular Graft Post-Approval Study

Abdominal Aortic Aneurysm (AAA) | Aorto-iliac Aneurysm | Juxtarenal Aneurysm

United States
Swiss Group for Clinical Cancer Research

Terminated

Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer

Adenocarcinoma | Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.

Lung Cancer | KRAS Gene Mutation | Advanced Non-small Cell Lung Cancer

Switzerland
Cook Research Incorporated

Completed

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study

Iliac Aneurysms | Aortoiliac Aneurysms

United States
Swiss Group for Clinical Cancer Research

Terminated

Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma (OptiPOM)

Refractory Multiple Myeloma

Switzerland
Cook Research Incorporated

Completed

VIVO Clinical Study

Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein

United States, Taiwan
Cook Research Incorporated

No longer available

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

Iliac Aneurysms | Aortoiliac Aneurysms

United States
Chinese Pulmonary Vascular Disease Research Group

Completed

The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease

Hypertension | Metabolic Disorder
Spanish Breast Cancer Research Group
AstraZeneca

Active, not recruiting

Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer (FLIPPER)

Breast Neoplasms

Spain, Ireland
Cook Research Incorporated

Approved for marketing

Zenith® Dissection Endovascular System in the Treatment of Patients With Aortic Dissections

Aortic Dissection

United States
Chinese Pulmonary Vascular Disease Research Group

Completed

Evaluation of Association Between Obstructive Sleep Apnea and the Severity of Coronary Artery Disease

Coronary Artery Disease

China
Swiss Group for Clinical Cancer Research

Completed

Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Prostate Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

Switzerland
Evgen Pharma
Premier Research Group plc

Completed

SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer (STEM)

Breast Neoplasm

United Kingdom, Belgium, France, Spain
Spanish Breast Cancer Research Group
Sanofi

Completed

Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients

Breast Cancer

Spain
Swiss Group for Clinical Cancer Research

Completed

Biological Therapy in Treating Patients With Bladder Cancer

Bladder Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumor

France, Switzerland, Germany, Finland
Swiss Group for Clinical Cancer Research

Completed

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myeloproliferative Neoplasm

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer

Liver Cancer

Switzerland, Austria, Hungary
Swiss Group for Clinical Cancer Research

Completed

Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer

Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Malignant Mesothelioma

Switzerland, Germany
Swiss Group for Clinical Cancer Research

Completed

Metronomic Therapy in Metastatic Breast Cancer.

Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma

Lymphoma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC

Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Liver Cancer

Switzerland, Netherlands
Swiss Group for Clinical Cancer Research

Completed

PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Lymphoma

Switzerland, Italy
Galician Research Group on Digestive Tumors

Completed

Gemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma. (ANICE-PaC)

Metastatic Pancreatic Cancer
Swiss Group for Clinical Cancer Research

Withdrawn

Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

Prostate Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Lymphoma

France, Switzerland, Italy
Queen's University
Glaucoma Research & Education Group

Withdrawn

Effect of an Anterior Chamber Infusion System on Trabeculectomy Outcomes

Glaucoma

Canada
Swiss Group for Clinical Cancer Research

Completed

Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Melanoma (Skin)

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Drugs to Reduce the Side Effects of Chemotherapy

Unspecified Adult Solid Tumor, Protocol Specific | Nausea and Vomiting

Switzerland, Italy
Swiss Group for Clinical Cancer Research

Completed

Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery

Esophageal Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Esophageal Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma

Lymphoma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer

Pain | Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement

Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

Prostate Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Chemotherapy in Treating Patients With Advanced Sarcoma

Sarcoma | Ovarian Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer

Gastric Cancer

Switzerland, Italy
Swiss Group for Clinical Cancer Research

Completed

Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer

Breast Cancer

Switzerland

Clinical Trials Sponsored by Evolution Research Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations